Action required: Please refresh your browser
We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.
More details about this topic are available here »
Home Healthcare Market Worth $383.0 Billion | MarketsandMarkets™. | ||||||||||||||||||||||||||||
By: PR Newswire Association LLC. - 06 Feb 2024 | Back to overview list |
|||||||||||||||||||||||||||
CHICAGO, Feb. 6, 2024 /PRNewswire/ -- Home Healthcare Market in terms of revenue was estimated to be worth $250.0 billion in 2023 and is poised to reach $383.0 billion by 2028, growing at a CAGR of 8.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. The primary drivers propelling the growth of this market are the aging population, rising healthcare expenditures, and the increased need for home care due to technological advancements in home healthcare. Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=696 Browse in-depth TOC on "Home Healthcare Market" 288 - Tables Home Healthcare Market Scope:
The therapeutic products segment accounted for the largest share of the home healthcare market, by product segment, in 2022 The home healthcare market is segmented into testing, screening, and monitoring products; therapeutic products; and mobility care products. In 2022, the home healthcare market will be dominated by therapeutic items, primarily because chronic illnesses like diabetes, cancer, and kidney failure are becoming more common. Infusion therapy services segment secured the highest growth rate during the study period The home healthcare market on the basis of service is divided into skilled nursing services, rehabilitation therapy services, hospice & palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, and pregnancy care services. Skilled nursing services have the biggest market share for home healthcare in 2022. The industry is expanding due to factors including the aging population. The other indications segment hold the largest share of the home healthcare, by indication segment, in 2022 On the basis of the indication, the home healthcare market has been segregated into cancer, respiratory diseases, movement disorders, cardiovascular diseases & hypertension, pregnancy, wound care, diabetes, hearing disorders, and other indications. By 2022, the home healthcare market's greatest share belonged to the other indications category. The growing older population and kidney problems are the main factors propelling this market's expansion. North America is the largest regional market for home healthcare market The global home healthcare market is segmented into four major regions—North America, Europe, the Asia Pacific, and Rest of the World. North America held the biggest market share for home healthcare in 2022. Due to its high disposable income and growing senior population, North America accounts for a sizable portion of the global industry. On the other hand, throughout the course of the forecast period, the Asia Pacific market is anticipated to develop at the highest CAGR. Rising disposable income and government initiatives to promote home healthcare are the main factors driving growth in the Asia Pacific home healthcare industry. Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=696 Home Healthcare Market Dynamics: Drivers: 1. Sharp increase in the number of older people and the prevalence of chronic illnesses Restraint: 1. Limited insurance coverage Opportunities: 1. Growing focus on newer technologies such as telehealth Challenge: 1. Shortage of homecare workers Key Market Players of Home Healthcare Industry: The major players operating in home healthcare market are Fresenius SE & Co. KGaA (Germany), Abbott (US), Koninklijke Philips N.V. (Netherlands), GE Healthcare (US), ResMed, Inc. (US), Linde, Plc (Ireland), F.Hoffmann-La Roche, Ltd. (Switzerland), A&D Company, Limited (Japan), Bayada Home Health Care (US), Invacare Corporation (US), Amedisys (US), LHC Group, Inc. (US), Omron Corporation (Japan), Drive Devilbiss Healthcare (UK), Hamilton Medical (Switzerland), Sunrise Medical (Germany), Roma Medical (UK), Caremax Rehabilitation Equipment Co., Ltd. (China), Vitalograph (UK), Advita Pflegedienst Gmbh (Germany), Renafan Gmbh (Germany), ADMR (France), Apex Medical Corp. (Taiwan), Contec Medical Systems Co., Ltd. (China), Löwenstein Medical Technology Gmbh + Co., KG. (Germany), B. Braun Melsungen Ag (Germany), Baxter International, Inc. (US), Allied Healthcare Products, Inc. (US), Medline Industries, Inc. (US), and Advin Health Care (India). Breakdown of supply-side primary interviews, by company type, designation, and region:
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=696 Home Healthcare Market - Key Benefits of Buying the Report: The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall home healthcare market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities. The report provides insights on the following pointers:
Related Reports: Telehealth & Telemedicine Market - Global Forecasts to 2028 IoT Medical Devices Market - Global Forecasts to 2028 Wound Care Market - Global Forecasts to 2028 Insulin Delivery Devices Market - Global Forecasts to 2028 Healthcare IT Market - Global Forecasts to 2027 About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's best management consulting firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. We have the widest lens on emerging technologies, making us proficient in co-creating supernormal growth for clients. Earlier this year, we made a formal transformation into one of America's best management consulting firms as per a survey conducted by Forbes. The B2B economy is witnessing the emergence of $25 trillion of new revenue streams that are substituting existing revenue streams in this decade alone. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we work with several Forbes Global 2000 B2B companies - helping them stay relevant in a disruptive ecosystem. Our insights and strategies are molded by our industry experts, cutting-edge AI-powered Market Intelligence Cloud, and years of research. The KnowledgeStore™ (our Market Intelligence Cloud) integrates our research, facilitates an analysis of interconnections through a set of applications, helping clients look at the entire ecosystem and understand the revenue shifts happening in their industry. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook. Contact: Logo: https://mma.prnewswire.com/media/2297424/MarketsandMarkets_Logo.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/home-healthcare-market-worth-383-0-billion--marketsandmarkets-302054252.html SOURCE MarketsandMarkets |
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Copyright 2024 PR Newswire Association LLC. | Back to overview list |